To compare the effects of metformin with diet & exercise on ovulation & menstrual regularity in PCOS infertile women .Study Design: Randomized clinical trial.Place & Duration of study: Private hospital infertility clinic at Karachi from 2001-2004.Patients & Methods: One hundred & eleven PCOS women with primary infertility were enrolled. and divided into group A & B with 57 & 54 patientsrespectively. Group A received tablet metformin 500mg thrice daily along with diet & exercise advice while group B was kept on diet & exercise alone(30-60 minutes walk daily & avoidance of oily foods, red meat & bakery products) for a period of 90 days. Menstrual regularity & plasma progesteronelevel were evalua...
Background: Metformin, an insulin-sensitizing agent, has been used successfully as the first-line dr...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
Objective: The aim of the study was to compare the effects of 16-week treatment with two insulin-low...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Objective: To determine whether women with polycystic ovary syndrome (PCOS) and abnormal insulin lev...
Polycystic Ovarian Syndrome (PCOS) is a heterogeneous multifactorial disorder in which the ovarian d...
Background: Objective of the study was to measure the efficacy and safety of insulin sensitizing dru...
Background: Objective of the study was to measure the efficacy and safety of insulin sensitizing dru...
Background: Polycystic ovarian syndrome (PCOS) characterized by anovulation and features of hyperand...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting reprodu...
Short-term use of metformin (Glucophage) improves ovulation rates for women with polycystic ovary sy...
Background: Metformin, an insulin-sensitizing agent, has been used successfully as the first-line dr...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
Objective: The aim of the study was to compare the effects of 16-week treatment with two insulin-low...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Objective(s): To evaluate the effects of metformin on insulin resistance, ovarian androgen productio...
Objective: To determine whether women with polycystic ovary syndrome (PCOS) and abnormal insulin lev...
Polycystic Ovarian Syndrome (PCOS) is a heterogeneous multifactorial disorder in which the ovarian d...
Background: Objective of the study was to measure the efficacy and safety of insulin sensitizing dru...
Background: Objective of the study was to measure the efficacy and safety of insulin sensitizing dru...
Background: Polycystic ovarian syndrome (PCOS) characterized by anovulation and features of hyperand...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting reprodu...
Short-term use of metformin (Glucophage) improves ovulation rates for women with polycystic ovary sy...
Background: Metformin, an insulin-sensitizing agent, has been used successfully as the first-line dr...
To evaluate whether pretreatment with metformin improves FSH-induced ovulation in women with clomiph...
Objective: The aim of the study was to compare the effects of 16-week treatment with two insulin-low...